Literature DB >> 14720320

Isolation of p53-target genes and their functional analysis.

Yusuke Nakamura1.   

Abstract

Mutations of the p53 gene are the most common genetic alterations found in human cancers, and are known to play crucial roles in tumor development and progression. The p53 gene encodes a protein functioning as a transcription factor, and the biological functions of p53 are manifested through the activities of its downstream genes. Identification of these downstream genes involved in the p53-signaling pathway should provide more detailed insight into the molecular mechanisms that mediate tumor-suppressor activities, as well as various responses to cellular stress. We have been attempting to isolate p53-target genes by means of various approaches, including differential display, cDNA microarray analysis, and direct cloning of the p53-binding sequences from human genomic DNA. Here I review our recent work on isolation of p53-target genes and their functional analysis. The physiological functions of p53-target genes include apoptosis (GML, p53AIP1, and STAG1), DNA repair (p53R2), inhibition of angiogenesis (BAI1), re-entry into the cell cycle (p53RFP), oxidative stress (CSR), and determination of cell fate (p53RDL1).

Entities:  

Mesh:

Year:  2004        PMID: 14720320     DOI: 10.1111/j.1349-7006.2004.tb03163.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  46 in total

1.  Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.

Authors:  Jamie M Hearnes; Deborah J Mays; Kristy L Schavolt; Luojia Tang; Xin Jiang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

2.  Differential recognition of response elements determines target gene specificity for p53 and p63.

Authors:  Motonobu Osada; Hannah Lui Park; Yuichi Nagakawa; Keishi Yamashita; Alexey Fomenkov; Myoung Sook Kim; Guojun Wu; Shuji Nomoto; Barry Trink; David Sidransky
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

3.  What's new in p53?

Authors:  D Maritsi; D Stagikas; K Charalabopoulos; A Batistatou
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

4.  The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.

Authors:  Yoshiko Masuda; Manabu Futamura; Hiroki Kamino; Yasuyuki Nakamura; Noriaki Kitamura; Shiho Ohnishi; Yuji Miyamoto; Hitoshi Ichikawa; Tsutomu Ohta; Misao Ohki; Tohru Kiyono; Hiroshi Egami; Hideo Baba; Hirofumi Arakawa
Journal:  J Hum Genet       Date:  2006-08-02       Impact factor: 3.172

Review 5.  p53 and mitochondrial function in neurons.

Authors:  David B Wang; Chizuru Kinoshita; Yoshito Kinoshita; Richard S Morrison
Journal:  Biochim Biophys Acta       Date:  2014-01-08

6.  CLCA2 as a p53-inducible senescence mediator.

Authors:  Chizu Tanikawa; Hidewaki Nakagawa; Yoichi Furukawa; Yusuke Nakamura; Koichi Matsuda
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

7.  Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.

Authors:  Erik S Zimmerman; Junjie Chen; Joshua L Andersen; Orly Ardon; Jason L Dehart; Jana Blackett; Shailesh K Choudhary; David Camerini; Paul Nghiem; Vicente Planelles
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 8.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

9.  Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F₁F0-ATP synthase.

Authors:  Marie Bergeaud; Lise Mathieu; Arnaud Guillaume; Ute M Moll; Bernard Mignotte; Nathalie Le Floch; Jean-Luc Vayssière; Vincent Rincheval
Journal:  Cell Cycle       Date:  2013-08-06       Impact factor: 4.534

10.  Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.

Authors:  Ten-i Godai; Tetsuji Suda; Nobuhiro Sugano; Kazuhito Tsuchida; Manabu Shiozawa; Hironobu Sekiguchi; Akiko Sekiyama; Mitsuyo Yoshihara; Shoichi Matsukuma; Yuji Sakuma; Eiju Tsuchiya; Yoichi Kameda; Makoto Akaike; Yohei Miyagi
Journal:  BMC Cancer       Date:  2009-12-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.